Rohtak: Rohtak PGIMS has completed the first phase of research of Corona's foreign vaccine. With 4 new volunteers, the dose of vaccine has now increased to 20. In these 4 volunteers, a woman and 3 men have come. A full investigation will be conducted after two weeks of dosing to all these volunteers. It will be seen that what is the condition of anti body in their body. In these two weeks, all these volunteers are in contact with the expert doctor of the institute.

The Chief Nodal Officer of the state, Coronavirus and Research Co-Investigator Dr. Dhruv Chaudhary said that with the grant of vaccine doses to 4 volunteers, a trial of 20 volunteers has been completed in the first phase. No ill effects of any kind have been seen so far in any volunteer. All four patients are perfectly healthy there. Principal Investigator of Research, Dr. Savita Verma has said that the health of volunteers is being monitored. The entire team of the institute is united in this work. In this project, his co-investigator Dr. Ramesh Verma is also involved.

The research of the double blind indigenous vaccine of Corona running in 12 major institutes of the country is the eye of the whole world. This research is called double blind because neither doctor knows about the dose of vaccine given to the patient. Neither to the patient. The doctor has to remember that there is no ill effect after the dose is administered. Based on a sample examination of volunteers, the lab tells how effective the vaccine is.

Also Read-

Besides Corona, this problem trouble Delhi, cases of dengue, malaria and chikungunya increased

Woman dies due to water logging in Telangana

IIT Kharagpur makes cheapest corona testing kit, results will come on your mobile